TruthArchive.ai - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary
There are weapons being developed to target specific individuals by using their DNA and medical profiles. This raises concerns about privacy, especially in terms of commercial data protection. Over the past 20 years, expectations of privacy have diminished, particularly among younger generations. People willingly provide their DNA to companies like 23andMe, which then own and can potentially sell this data without sufficient intellectual property or privacy safeguards. The lack of legal and regulatory frameworks to address these issues is a problem. It is crucial to have an open and public political discussion about how to protect healthcare information, DNA data, and personal data, as adversaries may exploit this information for developing such weapon systems.

Video Saved From X

reSee.it Video Transcript AI Summary
23andMe is mentioned, prompting a warning against using their services due to data selling practices. It is claimed that 23andMe sells user data to other entities, including Russia. Nathaniel Johnson, a policy advisor for the U.S. Department of the Treasury, is introduced. The claim is made that 23andMe's contract contains a clause allowing them to share information with shareholders, some of whom are pharmaceutical companies based in other countries. These foreign pharmaceutical companies are allegedly owned by entities such as the Ministry of Defense in Russia or are based in China.

Video Saved From X

reSee.it Video Transcript AI Summary
Kevin McKernan provides a whirlwind tour of DNA contamination in vaccines. He highlights the existence of DNA contamination in vaccines based on various studies and documents. McKernan criticizes the regulators' response, stating that they have turned to the vaccine manufacturers for answers, which he believes are misleading. He also discusses the use of different measurement methods and the potential risks associated with DNA contamination, including the integration of foreign DNA into human cells. McKernan calls for further screening of various biological samples for vaccine residue and encourages CLIA Laboratories to take an interest in this matter.

Video Saved From X

reSee.it Video Transcript AI Summary
But once you can probabilistically and through modeling, be able to much better see what's going to happen. Take for example, the fact that we already can start to see signs of Alzheimer's many, many decades potentially before a person starts to manifest the condition. Do they want to know? And if they don't want to know, should other people have the ability to know? Should an insurance company be able to make choices about whether to cover them? Should an employer have access to that information to make decisions about whether or not they auto, auto employ?

Video Saved From X

reSee.it Video Transcript AI Summary
A senator questions a 23andMe representative about their data privacy policies, specifically regarding the sale of consumer data. The senator claims the company's privacy statement says they cannot share information without consent, yet they are selling it. The representative states customers can delete their data anytime, even after the sale. The senator points out that the deletion page went down after the sale announcement. The representative claims the issue was fixed and customers can now delete their data. However, the senator reads from 23andMe's privacy policy, which states the company retains genetic information, date of birth, and sex even after account deletion. The representative initially denies retaining genetic information, but then admits to retaining name, email address, and other data. The senator accuses the company of not allowing consumers to permanently delete their data and lying to them. The senator concludes that 23andMe controls consumer data and is violating its promises.

Video Saved From X

reSee.it Video Transcript AI Summary
DNA companies are issuing warnings that your personal information can be sold and weaponized against you. It is claimed that someone's DNA and medical profile can be used to target a biological weapon that will kill that person. People are sending their DNA to companies like 23 and Me to get data about their background, but their DNA is now owned by a private company and can be sold off. There needs to be a public discussion about protecting healthcare and DNA information because this data will be collected by adversaries to develop these systems.

Video Saved From X

reSee.it Video Transcript AI Summary
A committee hearing is addressing privacy and national security concerns surrounding 23andMe's bankruptcy. 23andMe, a direct-to-consumer genetic testing company, filed for Chapter 11 bankruptcy, raising concerns about who will gain access to sensitive customer data. Regeneron Pharmaceuticals initially entered an agreement to acquire 23andMe, but the auction was reopened. Concerns exist regarding the storage, usage, and potential access by foreign adversaries to this private information, especially given 23andMe's past funding from investors linked to the Chinese Communist Party (CCP). Regeneron's partnership with a Chinese company also raises questions. The CCP's history of mass surveillance, bioweapon activities, and misuse of genetic data, including the hacking of 23andMe in 2023, are highlighted. In 2019, the Department of Defense warned military members against using consumer DNA kits due to security risks. Potential harm includes misuse by foreign actors, higher insurance premiums, credit restrictions, and targeted advertising. The committee seeks to understand how 23andMe will ensure the safety of Americans' genetic data and is hearing from 23andMe representatives.

Video Saved From X

reSee.it Video Transcript AI Summary
A committee hearing is addressing privacy and national security concerns regarding 23andMe's bankruptcy. 23andMe, a direct-to-consumer genetic testing company, filed for Chapter 11 bankruptcy, raising questions about who will access customers' sensitive genetic data. Regeneron Pharmaceuticals initially entered an agreement to acquire 23andMe, but the auction was reopened to allow bids from Regeneron and TTAM Research. Concerns exist regarding the storage, usage, and potential access by foreign adversaries to this private information, especially given 23andMe's past funding from investors, including WuXi Healthcare Ventures, linked to the CCP. Regeneron's partnership with a Chinese company, Xi Lab Ltd, is also noted. 23andMe was hacked in 2023, exposing nearly 7,000,000 profiles, mostly targeting Jewish and Chinese customers. The Department of Defense previously warned military members against using consumer DNA kits due to security risks. Potential harms include misuse by foreign actors, higher insurance premiums, credit restrictions, and targeted advertising. The committee seeks to understand how to ensure the safety of Americans' genetic data from Ann Wojciechie and Joseph Selzavage.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker discusses how the CIA uses Google to gather personal and biometric information, including DNA data from organizations like 23andme and ancestry.com. They warn against providing DNA information as it can be accessed by the CIA and Department of Defense. They mention the ARPA H program, an offshoot of the DOD's total information awareness program, which aims to collect medical information for both the CIA and DOD. The speaker emphasizes that we are now in the surveillance age and nothing we do is private.

Video Saved From X

reSee.it Video Transcript AI Summary
Mr. Kevin McKernan, a former leader at the Human Genome Project, discussed DNA contamination in Pfizer and Moderna vaccines. He highlighted the risks of insertional mutagenesis and integration into the genome, contradicting regulators' claims of little consequence. The DNA, found in lipid nanoparticles, can enter cells and potentially contribute to cancer. McKernan emphasized the inadequacy of current monitoring methods and called for a review of regulatory practices. The presence of DNA in these vaccines challenges existing safety standards and raises concerns about long-term effects.

Video Saved From X

reSee.it Video Transcript AI Summary
DNA companies are under scrutiny for potentially selling and weaponizing personal DNA information. It is claimed that a person's DNA and medical profile could be used to target them with a biological weapon. Concerns are raised about individuals willingly submitting their DNA to companies like 23 and Me, resulting in private companies owning and potentially selling that data. It is argued that open discussions are needed regarding the protection of healthcare and DNA information. The speaker asserts that adversaries could procure and collect this data to develop harmful systems.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker discusses the issue of DNA contamination in mRNA COVID-19 vaccines and questions the FDA's handling of the situation. They explain that normally rigorous tests are required to ensure safety, but in this case, the FDA ignored those tests. The speaker also mentions that Moderna's own patent acknowledges concerns about DNA and insertional immunogenesis. They reveal that DNA fragments, including an antibiotic resistance gene and sequences from simian virus 40, were found in the vaccines. The speaker expresses shock at the FDA's lack of transparency and highlights the potential risks associated with DNA damage, such as cancer and birth defects.

Video Saved From X

reSee.it Video Transcript AI Summary
23andMe is mentioned, prompting a warning against using their services due to data selling practices. It is claimed that 23andMe sells user data to other entities, including Russia. Nathaniel Johnson, a policy advisor for the U.S. Department of the Treasury, is introduced. The claim is made that 23andMe's contract includes a clause allowing them to share information with shareholders, some of whom are pharmaceutical companies based in other countries. These foreign pharmaceutical companies are allegedly owned by entities like the Ministry of Defense in Russia or are based in China.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0 argues that Ancestry DNA was never about helping you find your family, but about tracking bloodlines, finding lost kings, rulers and disruptors who once threatened the system, and those who have returned in new bodies, lifetimes, and identities. History, they claim, is not linear; it loops, and the rulers of today know that old enemies are being reborn and will do anything to stop them from waking up. They assert that they can trace every bloodline, every descendant, every possible return of an old ruler, an exiled king, a lost revolutionary, and if someone is born with the wrong DNA, a genetic signature that once belonged to a threat to their system, they know immediately and can stop them before they wake up. The speaker asks if the elite care about being 5% Viking or 10% Italian, implying they do not; for thousands of years, power has been passed down through family lines not because of wealth or privilege, but because certain souls always return to the same genetic pools. They claim the rulers of the past practiced inbreeding to ensure their souls would return to their dynasty, kept extensive genealogy records to know who belonged to which bloodline, and created secret societies that only accept specific families because they believe power reincarnates within their lineage. They assert these elites have always been obsessed with tracking souls through DNA, and with modern technology they no longer have to guess. The real reason mass DNA collection programs were launched was to find and neutralize threats before they wake up. Since DNA testing became popular, intelligence agencies gained access to private DNA databases without consent, genetic data was bought, sold and cross-referenced against historical bloodlines, mapping ancient royal lineages, fallen empires, and revolutionary leaders to their modern descendants. They claim they are searching for someone, or many someones—the ones who opposed the system before, the ones who once sat on thrones never meant to return, the ones who have the power to remember and fight again. If they find you in their system, they act before you do: they discredit certain people before they rise to power, they silence those who start remembering too much, they neutralize threats before they can shake the system again. Because if you wake up, if you remember who you were, if you realize why you are really here, the cycle ends, the throne is taken back, and their illusion of control collapses forever. The final question: who were you before? This is not a game. The war for control did not start in this lifetime; it has been happening for centuries, for ages, for cycles upon cycles of reincarnation. And now, the system is collapsing, more people are waking up, and the ones in power are desperate to track, suppress, and erase those who were never meant to return. So ask yourself, why were you born in this time? Why does history feel familiar? Why do you feel drawn to certain places, symbols, eras as if you lived them before? You might not just be a person searching for your past. You might be the past searching for itself. And the ones who rule now, they know who you are. The only question is, do you?

Video Saved From X

reSee.it Video Transcript AI Summary
Some people are concerned about data mining and privacy issues, particularly with ChoicePoint, a company created by Republicans. ChoicePoint has access to vast amounts of personal data, including phone numbers, medical records, DNA, and more. They have been involved in controversial activities, such as providing inaccurate voter lists in Florida and falsifying DNA evidence in rape cases. This privatized spy function raises constitutional concerns and blurs the line between government and private surveillance. George Orwell would find this situation concerning.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0 questions Speaker 1 about the company's data deletion policy, specifically how long it takes and whether the data is permanently deleted. Speaker 1 states that genetic data is typically deleted automatically within 30 days and is gone forever. Speaker 0 then quotes the company's privacy statement, which says that the company retains genetic information, date of birth, and sex even after an account is deleted. Speaker 1 initially denies retaining genetic information but then admits to retaining some information, such as name and email address, but not genetic information. Speaker 0 reiterates that the privacy policy states the company retains genetic information, date of birth, and sex even after account deletion.

Video Saved From X

reSee.it Video Transcript AI Summary
23andMe filed for bankruptcy, and CEO Ann Wajiki is resigning. Shares dropped over 50% after the bankruptcy filing. 23andMe's database of human genetic information may be sold in bankruptcy proceedings. According to 23andMe's privacy statement, in the event of bankruptcy, merger, acquisition, reorganization, or sale of assets, personal information may be accessed, sold, or transferred. This means your DNA could be used in unforeseen ways, such as cloning or being sold to malicious actors who could use it to implicate you in crimes. Bioweapons are a possibility, as is insurance companies using DNA data to deny coverage. Instructions are provided on how to delete your data from 23andMe.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker discusses the issue of DNA contamination in mRNA COVID-19 vaccines and questions the FDA's handling of the situation. They explain that normally rigorous tests are required for genotoxicity and immunogenesis, but the FDA seemed to ignore these requirements. The speaker also mentions that Moderna's own patent acknowledges the concerns related to DNA and insertional immunogenesis. They reveal that DNA fragments, including an antibiotic resistance gene and sequences from simian virus 40, were found in the vaccines. The speaker expresses concern about the potential risks associated with DNA damage, such as cancer and birth defects. They criticize the FDA for downplaying the issue and emphasize the importance of transparency.

Video Saved From X

reSee.it Video Transcript AI Summary
Weapons are being developed to target specific individuals using their DNA and medical profiles. This raises privacy concerns, especially with the degradation of privacy expectations over the last twenty years. People willingly submit their DNA to companies like 23 and Me, resulting in private companies owning and potentially selling their DNA with minimal privacy protection. Current legal and regulatory systems are inadequate to address this. An open, public, and political discussion is necessary to determine how to protect healthcare information, DNA, and personal data, as adversaries will collect this data to develop these targeted weapon systems.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 1 advises against using 23andMe because they allegedly sell user information. Speaker 1 claims this data is sold not only to the US but also potentially to other countries, including Russia. Speaker 1 suggests some pharmaceutical companies that purchase this data are based in countries like Russia and may be owned by entities such as the Ministry of Defense.

Video Saved From X

reSee.it Video Transcript AI Summary
A member of the House Intelligence Committee, Congressman Jason Crow, has warned against using DNA testing services, stating that private companies could potentially use the collected material to develop bioweapons targeting individuals. While this may sound like something out of a James Bond movie, it is a concern due to the CRISPR gene editing technology, which makes it easier to create targeted bioweapons. One such company, 23andMe, is an American-owned California company that trades on the Nasdaq but has a Chinese investor. There are concerns about the transparency of data sharing with China. US officials worry about the lack of regulation and transparency surrounding the movement of medical data, as well as China's strategy of gathering biological data for various purposes.

Video Saved From X

reSee.it Video Transcript AI Summary
Kevin McKernan provides a whirlwind tour of DNA contamination in vaccines. He highlights the presence of DNA contamination in vaccines and the lack of proper disclosure by regulatory bodies. McKernan discusses the bait and switch tactics used during clinical trials and the fraudulent practices employed by Pfizer. He also emphasizes the potential risks associated with DNA contamination, including the integration of foreign DNA into human cells. McKernan calls for increased screening of blood banks, sperm banks, and other medical facilities for residual vaccine DNA. He concludes by urging CLIA Laboratories to take an interest in this issue and emphasizes the need for state-level action since the FDA has demonstrated complicity and fraud.

Video Saved From X

reSee.it Video Transcript AI Summary
Digital ID: what could possibly go wrong? The transcript recalls Kirstyama’s recent visit to India to meet Modi and top officials, promoting India’s nationwide digital ID system called Aadhaar. It then presents a provocative claim: cyber criminals are reportedly saying they have stolen the entire Aadhaar database—815,000,000 people's details, including names, addresses, identity confirmations, bank details, and more—and are allegedly selling the database for $80,000 at a time. It notes uncertainty about verification but says the story is circulating. The speaker emphasizes concerns about security and the practicality of such a system: if every aspect of a person’s life—passport, driving license, NHS records, criminal record, bank details, all transactions, bills, travel and flight records, vehicle taxes, council taxes, hospital appointments, arrest records, and other personal data—are stored in one place, how safe and secure can it be? The question is raised of whether the people running these systems can be trusted to protect data, given ongoing data breaches and thefts, including several large incidents in the past year within the country. There’s a rhetorical comparison to India’s example, suggesting that this is a test case for the security of a highly centralized digital ID system. The speaker notes that StarMove had previously used India as an example of how well such a system could work, implying skepticism about that portrayal with the closing line, “The ironic thing is that StarMove was just out there holding them up as an example of how well the system could work. Yeah. Right, Kia. We believe you.” Key points: - Aadhaar is India’s nationwide digital ID system. - Alleged theft of 815,000,000 Aadhaar records, with claims of selling the data in chunks for $80,000; verification of this claim is uncertain. - The aggregation of extensive personal data in one system raises concerns about security and trust in the guardians of the data. - Data breaches are frequent, including notable incidents in the past year. - The India example is presented as a cautionary reference, contrasting with prior praise from StarMove.

Video Saved From X

reSee.it Video Transcript AI Summary
Caution about long-term side effects of modifying people’s DNA and RNA to directly encode the ability to produce antibodies, and whether this could cause other mutations or downstream risks.

Sourcery

The Quiet Revolution in DNA Sequencing | Nucleus Genomics
Guests: Kian Sadeghi
reSee.it Podcast Summary
The episode centers on a founder’s vision for a consumer health platform that integrates full genome data with other health metrics to personalize medical insight and daily living. The guest describes whole-genome sequencing as a foundational data source that can influence assessments of disease risk, longevity, and even cognitive traits, while emphasizing that genetics is only part of the picture. The conversation covers the economics and logistics of building a scalable, regulation-conscious genetic testing business, including details about partnerships with established labs and sequencing companies, the shift from expensive, limited genotyping to accessible, comprehensive whole-genome reads, and the rationale for offering a broad, user-centered data platform rather than gatekeeping insights. Throughout, the host and guest explore how consumer access to genetic information could reshape medical practice, personal decision-making, and family planning, while also addressing concerns about how to communicate complex genetic risk information in a responsible, understandable way. The dialogue frequently returns to the tension between empowering individuals with their own data and the ethical considerations of presenting probabilistic risk factors, illustrating how design choices in the user interface and reporting can mitigate anxiety while conveying meaningful context. The interview traces the founder’s personal journey from a bedroom startup to a fundraising trajectory, highlighting the blend of technical depth, product vision, and a willingness to challenge traditional gatekeepers, all aimed at turning DNA into an actionable, real-time health platform. It closes with a look ahead at new product launches, broader analyses, and plans to scale the platform to hundreds of diseases and family-oriented features, underscoring the ambition to turn genetics into everyday guidance rather than a distant specialty.
View Full Interactive Feed